136 related articles for article (PubMed ID: 8492768)
1. Dosimetry of intraperitoneally administered radiolabeled antibodies.
Roeske JC; Chen GT; Brill AB
Med Phys; 1993; 20(2 Pt 2):593-600. PubMed ID: 8492768
[TBL] [Abstract][Full Text] [Related]
2. Experimental radioimmunotherapy.
Buchsbaum DJ; Langmuir VK; Wessels BW
Med Phys; 1993; 20(2 Pt 2):551-67. PubMed ID: 8492764
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Rogers BE; Roberson PL; Shen S; Khazaeli MB; Carpenter M; Yokoyama S; Brechbiel MW; LoBuglio AF; Buchsbaum DJ
Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
[TBL] [Abstract][Full Text] [Related]
4. Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations.
Yorke ED; Williams LE; Demidecki AJ; Heidorn DB; Roberson PL; Wessels BW
Med Phys; 1993; 20(2 Pt 2):543-50. PubMed ID: 8492763
[TBL] [Abstract][Full Text] [Related]
5. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
6. Introduction: radiolabeled antibody tumor dosimetry.
Buchsbaum DJ; Wessels BW
Med Phys; 1993; 20(2 Pt 2):499-501. PubMed ID: 8492757
[No Abstract] [Full Text] [Related]
7. Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.
Leichner PK; Kwok CS
Med Phys; 1993; 20(2 Pt 2):529-34. PubMed ID: 8492761
[TBL] [Abstract][Full Text] [Related]
8. Microdosimetric concepts in radioimmunotherapy.
Humm JL; Roeske JC; Fisher DR; Chen GT
Med Phys; 1993; 20(2 Pt 2):535-41. PubMed ID: 8492762
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy with radioactive nanoparticles: first results of dosimetry for vascularized and necrosed solid tumors.
Bouchat V; Nuttens VE; Lucas S; Michiels C; Masereel B; Féron O; Gallez B; Vander Borght T
Med Phys; 2007 Nov; 34(11):4504-13. PubMed ID: 18072516
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry of solid tumors.
Meredith RF; Johnson TK; Plott G; Macey DJ; Vessella RL; Wilson LA; Breitz HB; Williams LE
Med Phys; 1993; 20(2 Pt 2):583-92. PubMed ID: 8492767
[TBL] [Abstract][Full Text] [Related]
11. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
Langmuir VK; Fowler JF; Knox SJ; Wessels BW; Sutherland RM; Wong JY
Med Phys; 1993; 20(2 Pt 2):601-10. PubMed ID: 8492769
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
[TBL] [Abstract][Full Text] [Related]
13. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.
Sgouros G; Squeri S; Ballangrud AM; Kolbert KS; Teitcher JB; Panageas KS; Finn RD; Divgi CR; Larson SM; Zelenetz AD
J Nucl Med; 2003 Feb; 44(2):260-8. PubMed ID: 12571219
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled antibody tumor dosimetry. AAPM Nuclear Medicine Committee Task Group No.2 on Dosimetry of Radiolabeled Antibodies.
Med Phys; 1993; 20(2 Pt 2):497-610. PubMed ID: 8098505
[No Abstract] [Full Text] [Related]
15. Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes.
Palm S; Bäck T; Lindegren S; Hultborn R; Jacobsson L; Albertsson P
J Nucl Med; 2018 Apr; 59(4):646-651. PubMed ID: 29175984
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.
Meredith R; Torgue J; Shen S; Fisher DR; Banaga E; Bunch P; Morgan D; Fan J; Straughn JM
J Nucl Med; 2014 Oct; 55(10):1636-42. PubMed ID: 25157044
[TBL] [Abstract][Full Text] [Related]
17. Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.
Strand SE; Ljungberg M; Tennvall J; Norrgren K; Garkavij M
Med Biol Eng Comput; 1994 Sep; 32(5):551-61. PubMed ID: 7845072
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
Sharkey RM; Brenner A; Burton J; Hajjar G; Toder SP; Alavi A; Matthies A; Tsai DE; Schuster SJ; Stadtmauer EA; Czuczman MS; Lamonica D; Kraeber-Bodere F; Mahe B; Chatal JF; Rogatko A; Mardirrosian G; Goldenberg DM
J Nucl Med; 2003 Dec; 44(12):2000-18. PubMed ID: 14660727
[TBL] [Abstract][Full Text] [Related]
19. Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters.
Roeske JC; Chen GT; Atcher RW; Pelizzari CA; Rotmensch J; Haraf D; Montag A; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1539-48. PubMed ID: 2262379
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.
Andersson H; Cederkrantz E; Bäck T; Divgi C; Elgqvist J; Himmelman J; Horvath G; Jacobsson L; Jensen H; Lindegren S; Palm S; Hultborn R
J Nucl Med; 2009 Jul; 50(7):1153-60. PubMed ID: 19525452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
